Products & Services · Year Five

Multi-line and other specialty — Year Five

Arch Capital Group Multi-line and other specialty — Year Five increased by 9.8% to 5.6% in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.8%, from 5.1% to 5.6%. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

An increase suggests growth in specialty risk premiums or successful market penetration, while a decrease may indicate reduced underwriting appetite or competitive pressure.

Detailed definition

This metric represents the financial performance or underwriting activity of the multi-line and specialty insurance segm...

Peer comparison

Similar to segment-specific revenue or premium growth metrics reported by diversified global insurers and reinsurers.

Metric ID: acgl_segment_multi_line_and_other_specialty_year_five

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value4.6%4.5%4.5%5.1%5.6%
QoQ Change-2.2%+0.0%+13.3%+9.8%
YoY Change-2.2%+0.0%+13.3%+9.8%
Range4.5%5.6%
CAGR+21.7%
Avg YoY Growth+5.2%
Median YoY Growth+4.9%
Current Streak3 quarters growth

Frequently Asked Questions

What is Arch Capital Group's multi-line and other specialty — year five?
Arch Capital Group (ACGL) reported multi-line and other specialty — year five of 5.6% in Q4 2025.
How has Arch Capital Group's multi-line and other specialty — year five changed year-over-year?
Arch Capital Group's multi-line and other specialty — year five increased by 9.8% year-over-year, from 5.1% to 5.6%.
What does multi-line and other specialty — year five mean?
The financial performance of the multi-line and specialty insurance segment in the fifth year of the reporting period.